Insider Trading Summary for Cerevel Therapeutics Holdings, Inc. (CERE): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
21-Feb-24 4:54 PM View:	20-Feb-24 Gift 0	Perceptive Advisors LLC Director		Cerevel Therapeutics Holdings, Inc. - CERE	7% 10.09M to 10.79M	0	0	--	--	Show Txns Hide Txns

18-Oct-23 4:30 PM View:	16-Oct-23 Purchase $125.00M	Bain Capital Investors LLC 10% Owner		Cerevel Therapeutics Holdings, Inc. - CERE	8% 60.63M to 65.68M	0	0	--	--	Show Txns Hide Txns

13-Feb-24 10:00 PM View:	29-Aug-23 Gift 0	Greene Gabrielle E Director		Cerevel Therapeutics Holdings, Inc. - CERE	9% 44.57K to 48.41K	0	0	--	--	Show Txns Hide Txns

27-Dec-23 4:15 PM View:	22-Dec-23 Option Sale ($331.61K)	Dipietro Kenneth Chief Human Resources Officer		Cerevel Therapeutics Holdings, Inc. - CERE	45% 17.01K to 24.66K	0	0	--	--	Show Txns Hide Txns

09-Jun-23 4:15 PM View:	07-Jun-23 Grant 0	Riedel Norbert G Director		Cerevel Therapeutics Holdings, Inc. - CERE	8% 42.81K to 46.09K	0	0	--	--	Show Txns Hide Txns

28-Dec-23 4:15 PM View:	26-Dec-23 Option Exercise $31.66K	Tregoning Kathleen See Remarks		Cerevel Therapeutics Holdings, Inc. - CERE	100% 0 to 10.67K	0	0	--	--	Show Txns Hide Txns

09-Jun-23 4:15 PM View:	07-Jun-23 Grant 0	Giordano Douglas E. Director		Cerevel Therapeutics Holdings, Inc. - CERE	100% 0 to 3.28K	0	0	--	--	Show Txns Hide Txns

09-Jun-23 4:15 PM View:	07-Jun-23 Grant 0	Dekkers Marijn E Director		Cerevel Therapeutics Holdings, Inc. - CERE	1% 630.87K to 634.15K	0	0	--	--	Show Txns Hide Txns

21-Dec-23 8:27 PM View:	20-Dec-23 Option Sale ($326.79K)	Bodenrader Mark See Remarks		Cerevel Therapeutics Holdings, Inc. - CERE	560% 2.68K to 17.72K	0	0	--	--	Show Txns Hide Txns

08-Feb-24 7:19 PM View:	07-Feb-24 Option Sale ($89.78K)	Renger John Chief Scientific Officer		Cerevel Therapeutics Holdings, Inc. - CERE	81% 3.51K to 6.37K	0	0	--	--	Show Txns Hide Txns

28-Dec-23 4:15 PM View:	26-Dec-23 Planned Option Sale ($424.70K)	Sanchez Ramiro Chief Medical Officer		Cerevel Therapeutics Holdings, Inc. - CERE	100% 0 to 14.67K	0	0	--	--	Show Txns Hide Txns

18-Oct-23 4:30 PM View:	16-Oct-23 Purchase Duplicate $125.00M	Gordon Christopher R Director 10% Owner		Cerevel Therapeutics Holdings, Inc. - CERE	8% 60.63M to 65.68M	0	0	--	--	Show Txns Hide Txns

18-Oct-23 4:30 PM View:	16-Oct-23 Purchase Duplicate $125.00M	Koppel Adam Director 10% Owner		Cerevel Therapeutics Holdings, Inc. - CERE	8% 60.63M to 65.68M	0	0	--	--	Show Txns Hide Txns

09-Jun-23 4:15 PM View:	07-Jun-23 Grant 0	McKernan Ruth Director		Cerevel Therapeutics Holdings, Inc. - CERE	100% 0 to 3.28K	0	0	--	--	Show Txns Hide Txns

03-Nov-23 4:15 PM View:	01-Nov-23 Planned Option Sale ($753.25K)	Patrick Deval L Director		Cerevel Therapeutics Holdings, Inc. - CERE	100% 0 to 3.28K	0	0	--	--	Show Txns Hide Txns

21-Dec-23 8:21 PM View:	20-Dec-23 Option Sale ($292.94K)	Akamine Scott Chief Legal Officer		Cerevel Therapeutics Holdings, Inc. - CERE	1311% 0.51K to 7.24K	0	0	--	--	Show Txns Hide Txns

21-Dec-23 8:12 PM View:	20-Dec-23 Option Sale ($571.97K)	Altschuller Susan Chief Financial Officer		Cerevel Therapeutics Holdings, Inc. - CERE	100% 0 to 16.91K	0	0	--	--	Show Txns Hide Txns

21-Dec-23 8:18 PM View:	19-Dec-23 Option Exercise 0	Renaud Ronald C Jr President & CEO Director		Cerevel Therapeutics Holdings, Inc. - CERE	100% 0 to 244.31K	0	0	--	--	Show Txns Hide Txns

21-Dec-23 8:26 PM View:	19-Dec-23 Option Exercise 0	Burgess Paul D. See Remarks		Cerevel Therapeutics Holdings, Inc. - CERE	100% 0 to 45.73K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 4:15 PM View:	01-Apr-24 Planned Option Sale ($2.12M)	Coles N Anthony Director		Cerevel Therapeutics Holdings, Inc. - CERE	478% 2.7K to 15.64K	0	0	--	--	Show Txns Hide Txns

Cerevel Therapeutics Holdings, Inc. (CERE)

Last Year

03-May-23 -- 02-May-24

Company Sentiment

Other

Other

Two Year Chart

03-May-22 -- 02-May-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--